Carisma Therapeutics, Inc. (CARM)

Summit Materials Revenue

Carisma Therapeutics had revenue of $10.77M in the twelve months ending June 30, 2025, down -48.01% year-over-year. In the year 2024, Carisma Therapeutics had annual revenue of $19.63M with 31.59% growth.

• Revenue (ttm): $10.77M
• Revenue Growth: -48.01%
• P/S Ratio: 1.05
• Revenue / Employee: $234,065
• Employees: 46
• Market Cap: 11.28M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	19.63M	4.71M	31.59%
Dec 31, 2023	14.92M	5.09M	51.71%
Dec 31, 2022	9.83M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.